New Treatment Can Help Patients Living with Amyloid Light Chain Amyloidosis

Pharmacy Times^® interviewed Jason Valent, MD, of the Cleveland Clinic his recent CAEL-101 findings, and how it can help shape treatment for patients living with amyloid light chain amyloidosis. His research surrounding the therapy was presented at the 62^nd American Society of Hematology Annual Meeting & Exposition.

The full conversation can be found in the video above.